WASHINGTON – Congressman Mike Thompson (D-CA) last week joined a majority in the House of Representatives in support of bipartisan legislation to provide health care to 11 million children from working families.
The Children’s Health Insurance Program Reauthorization Act (H.R. 2) was approved by a vote of 289-139.
The bill is very similar to the legislation that President Bush vetoed twice in the 110th Congress.
“Investing Read the rest of this entry »

The US Food and Drug Administration has given marketing approval to a new drug that lowers levels of uric acid in the blood of patients with
gout: the current treatment for the condition was developed over 40 years ago. The new drug is called ULORIC (generic name febuxostat) and Takeda
Pharmaceuticals North America is the sole developer and marketer of the product in the US.
According to a statement from Takeda, febuxostat is a new highly potent Read the rest of this entry »

With the peanut butter scare making news — the latest in a series involving salmonella-contaminated foods including tomatoes, jalapeno peppers and E. coli-contaminated spinach — there again rises the public clamor for doing something.
In the not distant past, studies have confirmed that the people reasonably enough are very much concerned about the safety of the food they eat.
Only government has the expertise and authority to do something Read the rest of this entry »

A 12-year-old Boston Latin Academy student died over the weekend from complications of the flu, Boston school and public health officials confirmed yesterday, one of only a handful of deaths nationwide so far this flu season.
Hunter Pope was a seventh-grader at the school, according to a statement from the city’s school system. He is the first Massachusetts child known to have died of the flu this winter.
Dr. Anita Barry, director of the infectious Read the rest of this entry »

,
,
The first drug ever manufactured in genetically-modified animals is likely coming soon to the U.S. market. A panel of expert advisers to the FDA
that an experimental anti-clotting product developed by Framingham, MA-based GTC Biotherapeutics looks safe and effective enough to become a marketed product.
, based on documents that were made publicly available Wednesday morning. The FDA still hasn’t made a final decision; its deadline Read the rest of this entry »

The first baby born in 2009 at Resurrection Medical Center, 7435 W. Talcott Ave., Chicago, is a girl — 7-pound 13-ounce Julia Oleksy. She was delivered by Dr. Steven Bujewski, an obstetrician/gynecologist.
Julia’s official arrival time was shortly after midnight — at 12:39 a.m. Jan. 1. She is the first child of Joanna Kosmowska and Krzysztof Oleksy, of Des Plaines. The couple’s extended family members live in Poland.
To welcome the new arrival, Read the rest of this entry »

eDiets.com(R) and Lady of America Fitness Centers Complete First Phase of Meal Delivery Marketing Program
FORT LAUDERDALE, Fla., Feb. 24 /PRNewswire-FirstCall/ –
eDiets.com, Inc.
(NASDAQ: DIET)
,
a leading provider of convenient at-home diet, fitness and healthy lifestyle solutions, today announced that it has completed the first phase of its marketing program to promote the Company’s fresh meal delivery service at Lady of America Franchise Read the rest of this entry »

Lawrence, KS    Dec 21, 2008 in
[prMac.com] Venice & Santa Barbara, California – Spinning, the worldwide leader in indoor group cycling, has announced the iSPINNING fitness application available on the Apple(R) iPhone App Store. iSPINNING, free for a limited time only, is an innovative new cardio and cycling application that compiles real-time data for fitness tracking. iSPINNING is the first of a suite of health and fitness apps enabled by Read the rest of this entry »

Tuesday, February 3, 2009
THE PUBLICATION of a national policy on men’s health has been hailed as groundbreaking.
But the failure to provide additional resources to assist in the implementation of the recommendations contained in the document has been criticised.
The National Men’s Health Policy 2008-2013, launched last week by the Minister of State at the Department of Health and Children (DOHC) Mary Wallace, highlights the need Read the rest of this entry »

BEIJING, Dec. 29 (Xinhuanet) — The Food and Drug
Administration (FDA) recently approved the first drug that will help with
producing longer eyelashes, according to media reports Monday.
Latisse, produced by the company of Allergan, is
supposed to treat those who have hypotrichosis, a condition in which a person
does not have enough eyelashes. It will be available by prescription starting in
the first quarter of 2009.
The active ingredient Read the rest of this entry »